Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy

BACKGROUND: Complete tumour response (pCR) to neo-adjuvant chemo-radiotherapy for rectal cancer is associated with a reduction in local recurrence and improved disease-free and overall survival, but is achieved in only 20–30% of patients. Drug repurposing for anti-cancer treatments is gaining moment...

Descripción completa

Detalles Bibliográficos
Autores principales: Gash, K J, Chambers, A C, Cotton, D E, Williams, A C, Thomas, M G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520519/
https://www.ncbi.nlm.nih.gov/pubmed/28641310
http://dx.doi.org/10.1038/bjc.2017.175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520519/
https://www.ncbi.nlm.nih.gov/pubmed/28641310
http://dx.doi.org/10.1038/bjc.2017.175

Ejemplares similares